We are actively reviewing claims involving GLP-1 drugs such as Ozempic, Wegovy, Rybelsus, Trulicity, and Mounjaro , including cases involving: If you or a loved one experienced serious health problems after taking a GLP-1 medication, you may be entitled to financial compensation
The Journal of Nutrition , 134 (3), 489-492
Zepbound (tirzepatide): Approved in 2023 for chronic weight management
Sample values are clearly marked as demo records
The research on GLP-1s impact on addictive behaviors creates new treatment possibilities for patients facing substance use challenges alongside weight concerns
2 Meta-analyses involving over 12 studies confirm that weight gain increases both breast cancer-specific and all-cause mortality